FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, particularly to use of non-equvalent mobile protons, relating to different NMR stereoisomers of CEST-agent, in ratiometric imaging method using CEST and to complex lanthanide compounds (III), having at least two distinguishable by NMR stereoisomers in solution used as sensitive CEST-agents not depending on concentration.
EFFECT: distinguished by NMR stereoisomers of CEST-agent are applied as useful biomarkers of certain disease, preciously associated with these changes.
13 cl, 21 dwg, 10 ex
Title | Year | Author | Number |
---|---|---|---|
DRUG CARRIER FOR CONTRAST ENHANCEMENT IN MRT | 2009 |
|
RU2528104C2 |
POLYMER CARRIER OF DRUG PREPARATIONS FOR VISUALLY-ASSISSTED DELIVERY | 2008 |
|
RU2477146C2 |
LIPID BILAYER CARRIER FOR MEDICINAL AND IMAGING AGENTS | 2011 |
|
RU2577291C2 |
CHELATE AMPHIPHILIC POLYMERS | 2009 |
|
RU2519713C2 |
COMPOSITIONS OF METAL COMPLEXES | 2015 |
|
RU2710360C2 |
COMPOUNDS FOR SEPARATION OF REAR EARTH ELEMENTS AND S-, P-, D-METALS, SEPARATION METHODS, AND THEIR USE | 2018 |
|
RU2783526C2 |
ELIMINATION OF INVOLVEMENT OF CONTRAST AGENT CONCENTRATION IN MRT | 2007 |
|
RU2446829C2 |
NEW GADOLINIUM CHELATE COMPOUNDS WITH HIGH RELAXIVITY FOR USE IN MAGNETIC RESONANCE IMAGING | 2017 |
|
RU2755181C2 |
COMPOUND FOR DIAGNOSING TUMOURS EXPRESSING PSMA AND COMPOSITION BASED THEREON | 2019 |
|
RU2730507C1 |
COMPOSITIONS CONTAINING COMPLEXES OF METALS OF SERIES OF LANTHANIDES | 2015 |
|
RU2707070C2 |
Authors
Dates
2016-12-27—Published
2011-11-04—Filed